← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2019Last known activity
Apr 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 4 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05933720Lead sponsorN/AApr 1, 2023
- NCT05933720Reponsible party - principal investigatorN/AApr 1, 2023
- NCT05933720Study chairN/AApr 1, 2023
- NCT06367166Lead sponsorN/AApr 1, 2023
- NCT04360889Lead sponsorPhase 4Sep 1, 2019
Details
- Last known activity
- Apr 1, 2023